ArticleMicromachines2026
Fabrication of Paper Microfluidic Chips via Wax Soft Lithography.
Article in Micromachines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Paper-based microfluidic devices (μPADs) have attracted significant attention for point-of-care testing (POCT), environmental monitoring, and food safety due to their low cost, ease of use, and minimal instrument dependence. However, fabricating high-resolution and reproducible microchannels on paper remains challenging. Conventional methods such as wax printing, photolithography, and inkjet printing are limited by resolution or equipment cost. Here, we present a low-cost, high-resolution fabrication method for μPADs, termed wax soft lithography, which combines wax printing with soft lithography. Through this method, microchannels with a minimum width of 234 ± 62 μm were consistently produced, and complex patterns were successfully fabricated, demonstrating high precision and reproducibility. As a proof-of-concept demonstration of device functionality, the fabricated μPADs were used to detect glucose in spiked urine samples, showing a concentration-dependent colorimetric response. This method provides an effective route for rapid production of high-resolution μPADs in resource-limited settings. With further validation before practical applications, this method shows promise for future development in POCT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.